Atropos Health Secures $33M in Series B Funding to Enhance Personalized Real-World Evidence
Briefly

from siliconvalleyjournals.com3 weeks ago
Atropos Health's funding will be used to expand their Generative AI platform, GENEVA OSTM, which is widely utilized across healthcare institutions, data platforms, and life sciences companies.
siliconvalleyjournals.comhttps://siliconvalleyjournals.com/atropos-health-secures-33m-in-series-b-funding-to-enhance-personalized-real-world-evidence/
The company focuses on bridging evidence gaps in healthcare using their GENEVA OSTM platform to accelerate research, enhance patient outcomes, and support value-based performance.
siliconvalleyjournals.comhttps://siliconvalleyjournals.com/atropos-health-secures-33m-in-series-b-funding-to-enhance-personalized-real-world-evidence/
Atropos Health's evidence-generating applications aim to improve clinical decision-making and deliver cost-effective care personalized to individual patients, with long-standing partners already benefiting from these innovations.
siliconvalleyjournals.comhttps://siliconvalleyjournals.com/atropos-health-secures-33m-in-series-b-funding-to-enhance-personalized-real-world-evidence/
Read at siliconvalleyjournals.com
[
add
]
[
|
|
]